ASUA Inc. Logo

ASUA Inc.

Consulting and solutions provider enhancing logistics safety and efficiency with IoT and telecom.

246A | T

Overview

Corporate Details

ISIN(s):
JP3119640005
LEI:
Country:
Japan
Address:
名古屋市中村区黄金通一丁目11番地
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

ASUA Inc. is a specialized consulting and solutions provider focused on the logistics and transportation sectors. The company enhances operational safety, efficiency, and sustainability for logistics operators through its core business segments: Mobility Solutions and Network Solutions. The Mobility Solutions division provides logistics outsourcing services, data solutions leveraging IoT, and comprehensive driver safety programs. The Network Solutions division offers consulting and sales of telecommunications equipment. A central component of its service portfolio is the "TRYES Program," an integrated consulting and cloud platform designed to support safety activities, driver education, and overall business improvement within the transportation industry.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-04 08:00
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 23.3 KB
2025-10-01 09:00
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 22.1 KB
2025-09-26 09:01
Regulatory News Service
確認書
Japanese 8.1 KB
2025-09-26 09:00
Annual Report
有価証券報告書-第31期(2024/07/01-2025/06/30)
Japanese 2.3 MB
2025-09-04 08:01
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 22.8 KB
2025-02-13 08:01
Report Publication Announcement
確認書
Japanese 8.1 KB
2025-02-13 08:00
Interim Report
半期報告書-第31期(2024/07/01-2025/06/30)
Japanese 151.7 KB
2024-09-30 08:31
Post-Annual General Meeting Information
臨時報告書
Japanese 20.1 KB
2024-09-30 08:25
Registration Form
確認書
Japanese 8.1 KB
2024-09-30 08:24
Annual Report
有価証券報告書-第30期(2023/07/01-2024/06/30)
Japanese 2.4 MB
2024-09-17 08:00
Registration Form
訂正有価証券届出書(新規公開時)
Japanese 2.9 MB
2024-09-06 08:00
Registration Form
訂正有価証券届出書(新規公開時)
Japanese 2.9 MB
2024-08-23 08:00
Registration Form
有価証券届出書(新規公開時)
Japanese 5.8 MB

Automate Your Workflow. Get a real-time feed of all ASUA Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ASUA Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ASUA Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

QUIA PHARMA AB Logo
Develops biobetters by enhancing approved drugs with a patented drug delivery platform.
Sweden
QUIA
QUINSTREET, INC Logo
AI-driven marketplaces connecting consumers to brands in finance & home services on a pay-per-result basis.
United States of America
QNST
Qurient Co., Ltd. Logo
Biopharma developing novel drugs for cancer, inflammation, and infectious diseases.
South Korea
115180
Rafael Holdings, Inc. Logo
Invests in and develops novel therapeutics for cancer and rare diseases.
United States of America
RFL
RaQualia Pharma Inc. Logo
An R&D firm discovering novel small molecules for out-licensing to pharma partners.
Japan
4579
Recruit Holdings Co., Ltd. Logo
Global provider of HR tech (Indeed), staffing services, and business SaaS solutions.
Japan
6098
RELMADA THERAPEUTICS, INC. Logo
A clinical-stage biotech developing novel therapies for CNS diseases and oncology.
United States of America
RLMD
Renascience Inc. Logo
Develops innovative drugs and AI-powered medical devices for aging and hereditary diseases.
Japan
4889
Rentracks CO.,LTD. Logo
A pay-per-performance ad network with a closed ASP and comprehensive web consulting services.
Japan
6045
Replimune Group, Inc. Logo
Clinical-stage biotech developing oncolytic immunotherapies to treat a broad range of cancers.
United States of America
REPL

Talk to a Data Expert

Have a question? We'll get back to you promptly.